"10.1371_journal.pone.0150836","plos one","2016-03-03T00:00:00Z","Alok R Singh; Shweta Joshi; Muamera Zulcic; Michael Alcaraz; Joseph R Garlich; Guillermo A Morales; Yoon J Cho; Lei Bao; Michael L Levy; Robert Newbury; Denise Malicki; Karen Messer; John Crawford; Donald L Durden","Department of Pediatrics, Moores Cancer Center, UC San Diego Health System, La Jolla, CA, United States of America; SignalRx Pharmaceuticals, San Diego, CA, United States of America; Departments of Neurology and Neurosurgery, Stanford University School of Medicine, Stanford, CA, United States of America; Biostatistics Department, Moores Cancer Center, UC San Diego Health System, La Jolla, CA, United States of America; Department of Neurosurgery, UCSD Rady Childrens Hospital, La Jolla, CA, United States of America; Department of Pathology, UCSD Rady Childrens Hospital, La Jolla, CA, United States of America; Department of Neurosciences Division of Child Neurology, UCSD Rady Childrens Hospital, La Jolla, CA, United States of America; Division of Pediatric Hematology-Oncology, UCSD Rady Childrens Hospital, La Jolla, CA, United States of America","Conceived and designed the experiments: ARS SJ DLD. Performed the experiments: ARS SJ. Analyzed the data: LB KM YJC. Contributed reagents/materials/analysis tools: JRG GAM MLL JC RN DM ARS MZ MA DLD. Wrote the paper: SJ ARS DLD.","The authors have the following interests: Authors Joseph R. Garlich and Guillermo A. Morales are employed by SignalRx Pharmaceuticals. Dr. Durden discloses financial conflict of interest in SignalRx Pharmaceuticals and in the SF1126 drug. There are the following patents relating to material pertinent to this article (PI-3 kinase inhibitor prodrugs Patent no: 6,949,537). The relationship between Dr. Durden and SignalRx has been internally reviewed and approved by the University of California, San Diego in accordance with its conflict of interest policies. This study was funded in part by Cricket Corporation. There are no further patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2016","03","Alok R Singh","ARS",14,TRUE,3,2,3,3,TRUE,FALSE,FALSE,0,NA,FALSE
